Zimmer Biomet Holdings, Inc. (ZBH) Q1 2021 Earnings Results

Zimmer Biomet Holdings Beats on EPS, Stock Down 2.82%

Zimmer Biomet's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the stock reacted negatively, declining by 2.82%, possibly due to a lack of revenue details and guidance. Investors may be concerned about ongoing supply chain challenges despite management's optimistic outlook.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$1.71	N/A	+13.47%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding future performance. They acknowledged current challenges but emphasized their focus on recovery and growth.

Management highlighted ongoing recovery in demand across key markets.

They noted challenges in supply chain but expressed confidence in long-term growth.

Zimmer Biomet Holdings Beats on EPS, Stock Down 2.82%

Key numbers

Management commentary

Zimmer Biomet Holdings, Inc.

More earnings this week

Zimmer Biomet Holdings Beats on EPS, Stock Down 2.82%

Key numbers

Management commentary